Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

FoundationOne® Diagnostics Approved for TALZENNA®–XTANDI® Therapy

mCRPC occurs when prostate cancer grows and spreads to other parts of the body despite hormone therapy that lowers testosterone. HRR gene mutations are present in approximately 20-30% of patients with mCRPC.3 While treatment options have expanded...

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

vitamins, and supplements. About Recurrent C. difficile Infection (rCDI) Recurrent C. difficile infection is a gastrointestinal infection caused by C. difficile bacteria. rCDI is linked to dysbiosis of the gastrointestinal microbiome and is...

Hologic to Present New Data Demonstrating the Clinical Impact of the Breast Cancer Index® Test on Extended Endocrine Therapy Decisions

Inc. and its subsidiary, Biotheranostics, Inc., announced new data demonstrating how the Breast Cancer Index® (BCI™) Test results influence extended endocrine therapy decisions for patients with early-stage, hormone receptor-positive (HR+) breast...

Pathobiology 2026

the understanding of cellular and molecular mechanisms of disease. For Pathobiology 2026, we have preserved a successfully tested meeting schedule with the objective of maximizing the meeting experience for all attendees and increasing the focus on...

SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

awards TetraSOD® is safeguarded by 10 patents and backed by 17 peer-reviewed studies conducted since 2006, with the latest published in March 2026. Its efficacy at a daily dose of just 25 mg has been demonstrated in multiple human clinical trials,...

BIZENGRI® (Zenocutuzumab-zbco) Wins FDA Approval for NRG1 Fusion-Positive Cholangiocarcinoma, Says Partner Therapeutics

as a targeted treatment option in this setting. These data further highlight the essential role of comprehensive molecular testing, particularly tissue-based RNA-based sequencing, to reliably detect gene fusions such as NRG1 and ensure patients are...

Viralgen Teams with Elaaj Bio to Advance CDKL5 Deficiency Gene Therapy

by the AEMPS/EMA, and integrates services including plasmid production, process optimization, fill-finish, and in-house QC testing. With over 1,500 AAV batches produced, Viralgen provides reliable, efficient solutions bringing life-changing gene...

Amazon Pharmacy Expands Same-Day Delivery and Kiosk Access for New Ozempic® Pill

lines. "Amazon Pharmacy continues to provide customers expanded selection and reliable, convenient access to the latest treatments like the Ozempic pill for type 2 diabetes, helping reduce the friction that comes with accessing breakthrough...

Study Finds Testosterone Therapy Boosts Women’s Energy, Mood, and Quality of Life

Joi + Blokes, a telehealth platform specializing in diagnostic testing, personalized medicine, and hormone and menopause care, announced the publication of a new peer-reviewed study demonstrating that testosterone replacement therapy (TRT) in...

NurtureBio Launched Breast Milk–Inspired Synbiotic to Help Babies with Gut Issues

NurtureBio applies a research-first standard, including collaboration with academic partners and independent third-party testing for identity, purity, and quality. NurtureBio was created in response to the growing need for families to provide their...

2nd Annual MaxPotent Pharma Summit 2026

challenges and opportunities across the HPAPI value chain. Over two intensive days, the conference will highlight the latest developments in EU and global regulatory frameworks, emerging containment and isolation technologies, and state-of-the-art...

TruLeaf Medical Completes Second-Stage Valve Implantation in Two Patients

system for high-risk, no-other-option patients suffering from severe refractory heart failure due to severe TR. This latest milestone builds upon the company's landmark first-in-human procedures reported in September and December of 2025. In up to...

Incyte announces FDA approval of Jakafi XR for treating myelofibrosis, polycythemia vera, and graft-versus-host disease

generally occurs after 100 days of transplant. Both forms can affect multiple organ systems, including the skin, gastrointestinal (digestive) tract and liver.5 About Jakafi XR™ (ruxolitinib) Extended-Release Tablets Jakafi XR™ (ruxolitinib)...

Apertura Gene Therapy and Broad Institute scientists share data on TfR1 CapX™, a novel CNS-targeting capsid

aimed at accelerating discovery and enabling more breakthroughs across the field. "We look forward to sharing Apertura's latest updates with the broader gene therapy community at ASGCT this year," said Andrew Steinsapir, Acting CTO at Apertura and...

AbbVie submits FDA application for SKYRIZI® (risankizumab-rzaa) subcutaneous induction in adults with moderate to severe Crohn’s disease

About Crohn's Disease Crohn's disease is a chronic, systemic disease that manifests as inflammation within the gastrointestinal tract, most commonly in the area between the small intestine (ileum) and the colon, causing persistent diarrhea and...

Cellenkos, Inc. receives FDA clearance to begin Phase 2 trial of CK0801 (allogeneic cord blood-derived Tregs) for aplastic anemia

cord blood unit (CBU) collected and banked from a healthy normal donor who has met FDA requirements for screening and testing for transmissible disease, in compliance with 21 CFR Part 1271, Subpart C. The FDA previously granted Orphan Drug...

CRENESSITY® lowers glucocorticoid doses while maintaining androgen control in adults with classic congenital adrenal hyperplasia

irregularities, in addition to cardiometabolic and fertility issues in both sexes. The symptoms of high ACTH may include testicular adrenal rest tumors (TARTs). About CRENESSITY® (crinecerfont) CRENESSITY is a potent and selective oral...

Avantor® Expands Stability and Microbial Testing Facility to Enhance U.S. Biomanufacturing Infrastructure

the expansion of its North American quality control capabilities with the addition of advanced microbial and stability testing at its St. Louis manufacturing site. The investment builds on Avantor's established global quality infrastructure,...

Recent Innovations Showcased by Baxter

second half of 2026, with select geographic expansion planned later this year. The Dynamo Series smart stretcher, the latest innovation in Baxter’s leading portfolio of smart beds, surfaces and connected care solutions, is currently available in...

Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

“I have spent my career working to close the gaps in liver care, particularly in clinical settings where we have the greatest opportunity to change outcomes,” said Dr. Singal. “Far too many patients progress to a stage of liver disease when...